IFP Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

IFP Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,562	Closed	–	–	4680
2021 Q4	$0	Hold	1,562	–	–	﹤0.01%	3579
2021 Q3	$0	Hold	1,562	–	–	﹤0.01%	3540
2021 Q2	$0	Buy	1,562 +1,494	+2,197%	–	﹤0.01%	3371
2021 Q1	$0	Hold	68	–	–	﹤0.01%	3362
2020 Q4	$0	Sell	68 -48	-41%	-$117	﹤0.01%	3239
2020 Q3	$0	Buy	+116	New	+$371	﹤0.01%	3132
2017 Q4	–	Sell	-555	Closed	-$2K	–	4399
2017 Q3	$2K	Hold	555	–	–	﹤0.01%	3855
2017 Q2	$1K	Hold	555	–	–	﹤0.01%	4044
2017 Q1	$1K	Hold	555	–	–	﹤0.01%	3949
2016 Q4	$1K	Hold	555	–	–	﹤0.01%	3940
2016 Q3	$2K	Sell	555 -1,026	-65%	-$3.26K	﹤0.01%	3679
2016 Q2	$5K	Buy	+1,581	New	+$5.27K	﹤0.01%	3211
2016 Q1	–	Sell	-1,551	Closed	-$5K	–	4401
2015 Q4	$5K	Buy	+1,551	New	+$6.49K	﹤0.01%	3031

Other funds holding PDLI

Amalgamated Financial New York $12.6B AUM

IFP Advisors's PDLI Position: Q1 2022 in Review

IFP Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q1 2022, closing a stake of 1,562 shares.

IFP Advisors first reported a position in PDLI in Q4 2015 and held it in 13 quarters. The position peaked at $5K in Q2 2016. 5 funds tracked by Wall St. Rank hold PDLI as of Q1 2022.

IFP Advisors reported no remaining PDL BioPharma, Inc. position as of Q1 2022 after selling out during the quarter.
IFP Advisors sold 1,562 PDL BioPharma, Inc. shares in Q1 2022.
IFP Advisors first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 13 quarters.
IFP Advisors's PDL BioPharma, Inc. position peaked at $5K in Q2 2016.
5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.